Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
5/6/2026
NHC Seeks Public Feedback on Updated Rules for Managing Narcotic and P...
5/6/2026
NHSA Solicits Comments on National Body Part Coding System to Strength...
5/6/2026
China Formalizes Approval Framework for Clinical Use of Biomedical New...
5/6/2026
NHC Releases Trial Rules for Approving Clinical Use of Biomedical New ...
5/6/2026
NHC Issues Interim Rules Defining Boundaries Between Biomedical New Te...
5/5/2026
China Clears 14 Novel INDs Last Week, Spotlighting Obesity, Oncology a...
5/5/2026
Gyre Thera Closes $300M Cullgen Deal
5/5/2026
U.S. Lawmakers Push to Bar China Clinical Data From FDA Filings, Raisi...
5/5/2026
Windward Bio Raises $165M to Advance China-Origin Asthma Drug Into Pha...
5/5/2026
Chinese Insulin Wins FDA Approval, Marking Breakthrough Entry Into U.S...
5/5/2026
China Tightens Biopharma Supply Chain Controls, Raising Stakes for MNC...
More>>
Feature Articles
5/5/2026
A Strategic Playbook for Chinese Biotech Cross-Border Deals: Navigatin...
5/1/2026
A Biopharmaceutical Superpower: China's Rise, Its Limits, and What Com...
4/29/2026
China Partnerships Drive Biopharma Deal Surge to $79B in Q1 2026
4/29/2026
From fast follower to originator: How Asia is rewiring biopharma innov...
4/28/2026
China Imposes Four-Year Deadline on Conditionally Approved Drugs, Tigh...
4/27/2026
China Biopharma Financing Rebounds in March as AI Startups and Mega-De...
4/22/2026
China Biopharma Deal Activity Slows in Q1 2026, but Upfront Payments S...
4/22/2026
China's Push to Elevate Private Health Insurance Faces Structural Hurd...
4/21/2026
Chinese Biotech Commands One-Third of Global Pharma Deal Value in 16-M...
4/16/2026
China Deepens Opening of Biotech and Healthcare Sectors to Attract Glo...
4/16/2026
2026 Biotech Playbook: Hong Kong at the Centre of China's Globalisatio...
More>>
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit